Mirae Asset Global ETFs Holdings
NPCE icon

Mirae Asset Global ETFs Holdings’s Neuropace NPCE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Buy
12,150
+295
+2% +$4.43K ﹤0.01% 2465
2025
Q4 		$183K Buy
11,855
+559
+5% +$7.47K ﹤0.01% 2389
2025
Q3 		$116K Sell
11,296
-1,864
-14% -$17.6K ﹤0.01% 2592
2025
Q2 		$147K Buy
13,160
+4,972
+61% +$62.2K ﹤0.01% 2427
2025
Q1 		$101K Buy
8,188
+396
+5% +$4.96K ﹤0.01% 2632
2024
Q4 		$87.2K Buy
7,792
+304
+4% +$2.64K ﹤0.01% 2754
2024
Q3 		$52.2K Buy
+7,488
New +$54.8K ﹤0.01% 2907

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NPCE Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Neuropace (NPCE) stake by 2.5% in Q1 2026, buying an estimated $4.43K and bringing the position to 12,150 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #2465.

Mirae Asset Global ETFs Holdings first reported a position in NPCE in Q3 2024 and has held it in 7 quarters since. The position peaked at $183K in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 12,150 shares of Neuropace worth $160K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 295 Neuropace shares in Q1 2026, an estimated $4.43K.
  • Neuropace made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2465 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Neuropace in Q3 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Neuropace position peaked at $183K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.